Table 1.
Function | Gene symbol | Gene description | Fold changea |
---|---|---|---|
ToF | |||
Matrix organization and cell adhesion | ELN | Elastin | 3.9 |
POSTN | Periostin, osteoblast specific factor | 3.6 | |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 3.6 | |
COL1A1 | Collagen, type I, alpha 1 | 3.5 | |
COL1A2 | Collagen, type I, alpha 2 | 2.8 | |
ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 2.8 | |
COL5A1 | Collagen, type V, alpha 1 | 2.7 | |
VCAN | Versican | 2.7 | |
COL5A2 | Collagen, type V, alpha 2 | 2.6 | |
MMP16 | Matrix metallopeptidase 16 (membrane-inserted) | 2.5 | |
NID1 | Nidogen 1 | 2.3 | |
COL4A4 | Collagen, type IV, alpha 4 | 2.3 | |
COL4A1 | Collagen, type IV, alpha 1 | 2.1 | |
THBS1 | Thrombospondin 1 | 2.1 | |
LAMA2 | Laminin, alpha 2 | 2.1 | |
Trascription factors | EGR1 | Early growth response 1 | 4.5 |
FOS | FBJ murine osteosarcoma viral oncogene homolog | 4.0 | |
HIF3A | Hypoxia inducible factor 3, alpha subunit | 2.2 | |
IER2 | Immediate early response 2 | 2.1 | |
NFIL3 | Nuclear factor, interleukin 3 regulated | 2.0 | |
ASD | |||
Muscle development and contraction | ACTA1 | Actin, alpha 1, skeletal muscle | 9.6 |
NEB | Nebulin | 7.9 | |
MYOT | Myotilin | 6.4 | |
MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | 5.3 | |
KLHL41 | Kelch-like family member 41 | 4.8 | |
MUSTN1 | Musculoskeletal, embryonic nuclear protein 1 | 4.1 | |
PPP1R3A | Protein phosphatase 1, regulatory subunit 3A | 3.9 | |
ENO3 | Enolase 3 (beta, muscle) | 3.6 | |
SYNPO2 | Synaptopodin 2 | 3.4 | |
MYH11 | Myosin, heavy chain 11, smooth muscle | 2.0 | |
MURC | Muscle-related coiled-coil protein | 2.0 |
Comparative analysis of gene expression in ToF and ASD samples was conducted as described in “Methods” section. A function, a gene symbol, a brief gene description, and the fold change values are specified for each gene
Genes for each functional category are ordered according to decreasing fold changes
aFold change ≥ 2 are considered significant